CKLSF (CK Life Sciences International Holdings) Other Stockholders Equity: $-290.6 Mil (As of Dec. 2025)


CKLSF CK Life Sciences International Holdings Inc CKLSF
34 GF Score
Price $0.09
GF Value $0.11
! 5 Warning Signs
View Full Analysis

What is CK Life Sciences International Holdings Other Stockholders Equity?

CK Life Sciences International Holdings CKLSF +28.57% 34 Other Stockholders Equity is $-290.6 Mil as of Dec. 2025. GuruFocus rates CKLSF with a GF Score™ of 34/100 and a GF Value™ of $0.11. The stock has 5 warning signs investors should review.

CK Life Sciences International Holdings's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $-290.6 Mil.

CK Life Sciences International Holdings's quarterly Other Stockholders Equity increased from Dec. 2024 ($-356.2 Mil) to Jun. 2025 ($-315.6 Mil) and increased from Jun. 2025 ($-315.6 Mil) to Dec. 2025 ($-290.6 Mil).

CK Life Sciences International Holdings's annual Other Stockholders Equity declined from Dec. 2023 ($-284.0 Mil) to Dec. 2024 ($-356.2 Mil) but then increased from Dec. 2024 ($-356.2 Mil) to Dec. 2025 ($-290.6 Mil).

CK Life Sciences International Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for CK Life Sciences International Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CK Life Sciences International Holdings Other Stockholders Equity Chart

CK Life Sciences International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -247.15 -296.57 -284.00 -356.24 -290.59

CK Life Sciences International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -284.00 -306.55 -356.24 -315.57 -290.59
CKLSF
34GF Score
CK Life Sciences International Holdings Inc CKLSF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CK Life Sciences International Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-290.6 Mil mean?
CK Life Sciences International Holdings (CKLSF) has a Other Stockholders Equity of $-290.6 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on CK Life Sciences International Holdings and its competitors.
Is CK Life Sciences International Holdings' Other Stockholders Equity too high?
CK Life Sciences International Holdings' current Other Stockholders Equity is $-290.6 Mil. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Other Stockholders Equity compare to VRTX and REGN?
CK Life Sciences International Holdings' Other Stockholders Equity of $-290.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on CK Life Sciences International Holdings and its competitors. CK Life Sciences International Holdings's current Other Stockholders Equity is $-290.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (CKLSF) has a current Other Stockholders Equity of $-290.6 Mil. The stock's GF Value™ is $0.11, compared to a current price of $0.09 — trading 18.2% below its estimated fair value. The current Other Stockholders Equity is $-290.6 Mil. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For CK Life Sciences International Holdings (CKLSF), the current Other Stockholders Equity is $-290.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CK Life Sciences International Holdings (CKLSF) Overvalued in 2026?

Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued. The current stock price of $0.09 is trading 18.2% below its estimated GF Value™ of $0.11.

Key valuation signals for CKLSF:

  • Other Stockholders Equity: $-290.6 Mil
  • GF Value™: $0.11 vs. price of $0.09 (18.2% below fair value)
  • GF Score™: 34/100 with 5 warning signs

No single metric tells the full story. See the CKLSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CK Life Sciences International Holdings Business Description

Other Exchanges 00775:Hong Kong
Address 2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score

Get the complete analysis for CKLSF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price
$0.11
GF Value